These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21750289)

  • 1. Fibrate use in the United States and Canada.
    Lim LS; Wong TY
    JAMA; 2011 Jul; 306(2):157-8; author reply 158-9. PubMed ID: 21750289
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrate use in the United States and Canada.
    Tenenbaum A; Fisman EZ
    JAMA; 2011 Jul; 306(2):157; author reply 158-9. PubMed ID: 21750290
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of fibrates in the United States and Canada.
    Jackevicius CA; Tu JV; Ross JS; Ko DT; Carreon D; Krumholz HM
    JAMA; 2011 Mar; 305(12):1217-24. PubMed ID: 21427374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician variation in the de-adoption of ineffective statin and fibrate therapy.
    Everhart A; Desai NR; Dowd B; Herrin J; Higuera L; Jeffery MM; Jena AB; Ross JS; Shah ND; Smith LB; Karaca-Mandic P
    Health Serv Res; 2021 Oct; 56(5):919-931. PubMed ID: 33569804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrate use in diabetes: new concepts.
    Bloomgarden ZT; Drexler A
    J Diabetes; 2011 Mar; 3(1):1-2. PubMed ID: 21159144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrates: their prescription must be restricted].
    Béliard-Lasserre S
    Rev Prat; 2015 Dec; 65(10):1243-4. PubMed ID: 26979011
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary care physicians' practice patterns and diabetic retinopathy. Current levels of care.
    Kraft SK; Marrero DG; Lazaridis EN; Fineberg N; Qiu C; Clark CM
    Arch Fam Med; 1997; 6(1):29-37. PubMed ID: 9003167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenofibrate and diabetic retinopathy.
    Liew G; Gillies M; Wang JJ
    Lancet; 2008 Mar; 371(9614):721; author reply 722. PubMed ID: 18313494
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of Fibrates on Risk of Development of Diabetic Retinopathy in Japanese Working Age Patients with Type 2 Diabetes and Dyslipidemia: a Retrospective Cohort Study].
    Akimoto H; Takahashi Y; Asai S
    Yakugaku Zasshi; 2021; 141(5):761-769. PubMed ID: 33952760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlipidaemia and cardiovascular disease: do fibrates have a role?
    Saha SA; Arora RR
    Curr Opin Lipidol; 2011 Aug; 22(4):270-6. PubMed ID: 21519250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapies for diabetic retinopathy: the accord eye study.
    Frank RN
    Ophthalmology; 2014 Dec; 121(12):2295-6. PubMed ID: 25459462
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetic retinopathy: treatment and prevention.
    Dodson PM
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S9-S11. PubMed ID: 17935059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists.
    Vaduganathan M; Patel RB; Singh A; McCarthy CP; Qamar A; Januzzi JL; Scirica BM; Butler J; Cannon CP; Bhatt DL
    J Am Coll Cardiol; 2019 Apr; 73(12):1596-1598. PubMed ID: 30922481
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of fenofibrate in clinical practice.
    Zambon A; Cusi K
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S15-20. PubMed ID: 17935056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
    Peter R; Reilly E; Anthony S
    Curr Opin Lipidol; 2010 Dec; 21(6):554-5. PubMed ID: 21206346
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?
    Dodson PM
    Eye (Lond); 2009 May; 23(5):997-1003. PubMed ID: 19169236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription patterns. Where the medicine goes down.
    Haugh R
    Hosp Health Netw; 1998 Jul; 72(14):39. PubMed ID: 9714587
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrates in the treatment of dyslipidemias--time for a reassessment.
    Goldfine AB; Kaul S; Hiatt WR
    N Engl J Med; 2011 Aug; 365(6):481-4. PubMed ID: 21830963
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias.
    Suh HS; Hay JW; Johnson KA; Doctor JN
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):470-84. PubMed ID: 22461130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.
    Wanner C; Krane V
    Kidney Blood Press Res; 2011; 34(4):209-17. PubMed ID: 21691123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.